These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22104148)

  • 1. Synthesis, antitubercular evaluation and 3D-QSAR study of N-phenyl-3-(4-fluorophenyl)-4-substituted pyrazole derivatives.
    Khunt RC; Khedkar VM; Chawda RS; Chauhan NA; Parikh AR; Coutinho EC
    Bioorg Med Chem Lett; 2012 Jan; 22(1):666-78. PubMed ID: 22104148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, screening for antitubercular activity and 3D-QSAR studies of substituted N-phenyl-6-methyl-2-oxo-4-phenyl-1,2,3,4-tetrahydro-pyrimidine-5-carboxamides.
    Virsodia V; Pissurlenkar RR; Manvar D; Dholakia C; Adlakha P; Shah A; Coutinho EC
    Eur J Med Chem; 2008 Oct; 43(10):2103-15. PubMed ID: 17950956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, antitubercular and antimicrobial evaluation of 3-(4-chlorophenyl)-4-substituted pyrazole derivatives.
    Pathak RB; Chovatia PT; Parekh HH
    Bioorg Med Chem Lett; 2012 Aug; 22(15):5129-33. PubMed ID: 22695129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of 4-(adamantan-1-yl)-2-substituted quinolines.
    Nayyar A; Monga V; Malde A; Coutinho E; Jain R
    Bioorg Med Chem; 2007 Jan; 15(2):626-40. PubMed ID: 17107805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-QSAR study of ring-substituted quinoline class of anti-tuberculosis agents.
    Nayyar A; Malde A; Jain R; Coutinho E
    Bioorg Med Chem; 2006 Feb; 14(3):847-56. PubMed ID: 16214351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
    Shagufta ; Kumar A; Panda G; Siddiqi MI
    J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitubercular activity of substituted novel pyrazoline derivatives.
    Ali MA; Yar MS; Kumar M; Pandian GS
    Nat Prod Res; 2007 Jun; 21(7):575-9. PubMed ID: 17613813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors.
    Zeng H; Zhang H
    J Mol Graph Model; 2010 Aug; 29(1):54-71. PubMed ID: 20471293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-Hydroxythiosemicarbazones: synthesis and in vitro antitubercular activity.
    Sriram D; Yogeeswari P; Dhakla P; Senthilkumar P; Banerjee D
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1888-91. PubMed ID: 17276683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide analogues.
    Ahsan MJ; Samy JG; Dutt KR; Agrawal UK; Yadav BS; Vyas S; Kaur R; Yadav G
    Bioorg Med Chem Lett; 2011 Aug; 21(15):4451-3. PubMed ID: 21733688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of ring-substituted-2/4-quinolinecarbaldehyde derivatives.
    Nayyar A; Malde A; Coutinho E; Jain R
    Bioorg Med Chem; 2006 Nov; 14(21):7302-10. PubMed ID: 16843663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, structural activity relationship and anti-tubercular activity of novel pyrazoline derivatives.
    Ali MA; Shaharyar M; Siddiqui AA
    Eur J Med Chem; 2007 Feb; 42(2):268-75. PubMed ID: 17007966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and 3D-QSAR analysis of 2-chloroquinoline derivatives as H37 RV MTB inhibitors.
    Khunt RC; Khedkar VM; Coutinho EC
    Chem Biol Drug Des; 2013 Dec; 82(6):669-84. PubMed ID: 23790070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel substituted pyrazolyl-2-toluidinomethanethione and pyrazolyl-2-methoxyanilinomethanethione as potential antitubercular agents.
    Ali MA; Yar MS
    Acta Pol Pharm; 2007; 64(2):139-46. PubMed ID: 17665863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis.
    Vujasinović I; Paravić-Radičević A; Mlinarić-Majerski K; Brajša K; Bertoša B
    Bioorg Med Chem; 2012 Mar; 20(6):2101-10. PubMed ID: 22341245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea.
    Sriram D; Yogeeswari P; Madhu K
    Bioorg Med Chem Lett; 2006 Feb; 16(4):876-8. PubMed ID: 16303302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models.
    Bhongade BA; Gadad AK
    J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, in vitro antitubercular activity and 3D-QSAR of novel quinoxaline derivatives.
    Puratchikody A; Natarajan R; Jayapal M; Doble M
    Chem Biol Drug Des; 2011 Dec; 78(6):988-98. PubMed ID: 21951363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of novel quinazolinone derivatives as inhibitors for 5HT7 receptor.
    Chitta A; Jatavath MB; Fatima S; Manga V
    J Recept Signal Transduct Res; 2012 Feb; 32(1):3-16. PubMed ID: 22171569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D-QSAR studies of some tetrasubstituted pyrazoles as COX-II inhibitors.
    Gupta GK; Kumar A
    Acta Pol Pharm; 2012; 69(4):763-72. PubMed ID: 22876620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.